Cargando…
Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes: The TRANSCEND study
OBJECTIVE: Several large clinical trials suggest that ACE inhibitors may reduce the incidence of diabetes. Less is known about the effects of angiotensin receptor blockers (ARBs) on reducing incident diabetes or leading to regression of impaired fasting glucose (IFG) or impaired glucose tolerance (I...
Autores principales: | Barzilay, Joshua I., Gao, Peggy, Rydén, Lars, Schumacher, Helmut, Probstfield, Jeffrey, Commerford, Patrick, Dans, Antonio, Ferreira, Rafael, Keltai, Mátyás, Paolasso, Ernesto, Yusuf, Salim, Teo, Koon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161302/ https://www.ncbi.nlm.nih.gov/pubmed/21788624 http://dx.doi.org/10.2337/dc11-0545 |
Ejemplares similares
-
In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events
por: Dans, Antonio L., et al.
Publicado: (2010) -
Transcending the self to transcend suffering
por: Ge, Brian H., et al.
Publicado: (2023) -
Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
por: Neldam, Steen, et al.
Publicado: (2013) -
From Self-Transcendence to Collective Transcendence: In Search of the Order of Hierarchies in Maslow’s Transcendence
por: Llanos, Luis Felipe, et al.
Publicado: (2022) -
Arterial Stiffness and Pharmacological Interventions – The TRanscend Arterial stiffNess Substudy (TRANS study)
por: Topouchian, Jirar, et al.
Publicado: (2007)